Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Insmed Incorporated(INSM) | 1,300,000 | 1,550,000 | +250,000 | $35.27M | $103.85M | 10.34% | +$68.58M |
| Tenet Healthcare Corporation(THC) | 425,000 | 500,000 | +75,000 | $44.67M | $66.52M | 6.62% | +$21.84M |
| Cytokinetics, Incorporated(CYTK) | 450,000 | 1,000,000 | +550,000 | $31.55M | $54.18M | 5.39% | +$22.63M |
| Boston Scientific Corporation(BSX) | 600,000 | 650,000 | +50,000 | $41.09M | $50.06M | 4.98% | +$8.96M |
| Elevance Health, Inc.(ELV) | 50,000 | 80,000 | +30,000 | $25.93M | $43.35M | 4.31% | +$17.42M |
| Blueprint Medicines Corp | 210,000 | 340,000 | +130,000 | $19.92M | $36.65M | 3.65% | +$16.72M |
| Novartis AGADR(NVS) | 225,000 | 300,000 | +75,000 | $21.76M | $31.94M | 3.18% | +$10.17M |
| Longboard Pharmaceuticals In | 975,000 | 1,100,000 | +125,000 | $21.06M | $29.73M | 2.96% | +$8.67M |
| Merck & Co., Inc.(MRK) | 235,000 | 235,000 | 0 | $31.01M | $29.09M | 2.90% | -$1.92M |
| Humana Inc.(HUM) | 60,000 | 75,000 | +15,000 | $20.80M | $28.02M | 2.79% | +$7.22M |
| Encompass Health Corporation(EHC) | 350,000 | 300,000 | -50,000 | $28.90M | $25.74M | 2.56% | -$3.17M |
| Universal Health Services, Inc.CL B(UHS) | 125,000 | 130,000 | +5,000 | $22.81M | $24.04M | 2.39% | +$1.23M |
| Inari Med Inc | 200,000 | 400,000 | +200,000 | $9.60M | $19.26M | 1.92% | +$9.66M |
| Vera Therapeutics, Inc.CL A(VERA) | 360,000 | 500,000 | +140,000 | $15.52M | $18.09M | 1.80% | +$2.57M |
| Crinetics Pharmaceuticals In | 325,000 | 400,000 | +75,000 | $15.21M | $17.92M | 1.78% | +$2.70M |
| Becton, Dickinson and Company(BDX) | 0 | 75,000 | +75,000 | $0 | $17.53M | 1.74% | +$17.53M |
| The Cigna Group(CI) | 40,000 | 50,000 | +10,000 | $14.53M | $16.53M | 1.65% | +$2.00M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 590,000 | 590,000 | 0 | $21.45M | $16.04M | 1.60% | -$5.41M |
| Krystal Biotech, Inc.(KRYS) | 80,000 | 85,000 | +5,000 | $14.23M | $15.61M | 1.55% | +$1.38M |
| Arcellx Inc COMMON STOCK | 255,000 | 275,000 | +20,000 | $17.74M | $15.18M | 1.51% | -$2.56M |
| ICON Public Limited CompanySHS(ICLR) | 45,000 | 45,000 | 0 | $15.12M | $14.11M | 1.40% | -$1.01M |
| Edwards Lifesciences Corp | 0 | 150,000 | +150,000 | $0 | $13.86M | 1.38% | +$13.86M |
| Thermo Fisher Scientific Inc.(TMO) | 0 | 25,000 | +25,000 | $0 | $13.82M | 1.38% | +$13.82M |
| Quest Diagnostics Incorporated(DGX) | 0 | 100,000 | +100,000 | $0 | $13.69M | 1.36% | +$13.69M |
| Viking Therapeutics, Inc.(VKTX) | 450,000 | 250,000 | -200,000 | $36.90M | $13.25M | 1.32% | -$23.65M |
| Revolution Medicines, Inc.(RVMD) | 420,000 | 325,000 | -95,000 | $13.54M | $12.61M | 1.26% | -$923.4K |
| Amgen Inc.(AMGN) | 0 | 40,000 | +40,000 | $0 | $12.50M | 1.24% | +$12.50M |
| Ionis Pharmaceuticals, Inc.(IONS) | 0 | 250,000 | +250,000 | $0 | $11.91M | 1.19% | +$11.91M |
| McKesson Corporation(MCK) | 0 | 20,000 | +20,000 | $0 | $11.68M | 1.16% | +$11.68M |
| REGENXBIO Inc.(RGNX) | 760,000 | 950,000 | +190,000 | $16.01M | $11.12M | 1.11% | -$4.90M |
| Intra-Cellular Therapies Inc | 125,000 | 145,000 | +20,000 | $8.65M | $9.93M | 0.99% | +$1.28M |
| SanofiADR(SNY) | 0 | 200,000 | +200,000 | $0 | $9.70M | 0.97% | +$9.70M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 220,000 | 220,000 | 0 | $11.05M | $9.67M | 0.96% | -$1.38M |
| Neurocrine Biosciences, Inc.(NBIX) | 150,000 | 70,000 | -80,000 | $20.69M | $9.64M | 0.96% | -$11.05M |
| Teleflex Incorporated(TFX) | 0 | 45,000 | +45,000 | $0 | $9.46M | 0.94% | +$9.46M |
| Eli Lilly and Company(LLY) | 12,000 | 10,000 | -2,000 | $9.34M | $9.05M | 0.90% | -$281.7K |
| Globus Medical, Inc.CL A(GMED) | 0 | 125,000 | +125,000 | $0 | $8.56M | 0.85% | +$8.56M |
| Bruker Corporation(BRKR) | 220,000 | 130,000 | -90,000 | $20.67M | $8.30M | 0.83% | -$12.37M |
| CRISPR Therapeutics AGNAMEN AKT(CRSP) | 220,000 | 150,000 | -70,000 | $15.00M | $8.10M | 0.81% | -$6.89M |
| Oscar Health, Inc.CL A(OSCR) | 500,000 | 500,000 | 0 | $7.43M | $7.91M | 0.79% | +$475.0K |
| Repligen Corporation(RGEN) | 50,000 | 60,000 | +10,000 | $9.20M | $7.56M | 0.75% | -$1.63M |
| Denali Therapeutics Inc.(DNLI) | 0 | 325,000 | +325,000 | $0 | $7.55M | 0.75% | +$7.55M |
| Tenaya Therapeutics, Inc.(TNYA) | 2,250,000 | 2,325,000 | +75,000 | $11.77M | $7.21M | 0.72% | -$4.56M |
| Sana Biotechnology, Inc.(SANA) | 980,000 | 1,200,000 | +220,000 | $9.80M | $6.55M | 0.65% | -$3.25M |
| Elanco Animal Health Incorporated(ELAN) | 550,000 | 450,000 | -100,000 | $8.95M | $6.49M | 0.65% | -$2.46M |
| Mereo BioPharma Group plcADS(MREO) | 950,000 | 1,775,000 | +825,000 | $3.13M | $6.39M | 0.64% | +$3.25M |
| Merus N V | 165,000 | 100,000 | -65,000 | $7.43M | $5.92M | 0.59% | -$1.51M |
| Insulet Corporation(PODD) | 0 | 25,000 | +25,000 | $0 | $5.04M | 0.50% | +$5.04M |
| QuidelOrtho Corporation(QDEL) | 0 | 150,000 | +150,000 | $0 | $4.98M | 0.50% | +$4.98M |
| Relay Therapeutics, Inc.(RLAY) | 725,000 | 750,000 | +25,000 | $6.02M | $4.89M | 0.49% | -$1.13M |
| Surgery Partners, Inc.(SGRY) | 0 | 200,000 | +200,000 | $0 | $4.76M | 0.47% | +$4.76M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 0 | 100,000 | +100,000 | $0 | $4.53M | 0.45% | +$4.53M |
| Intuitive Surgical, Inc.(ISRG) | 50,000 | 10,000 | -40,000 | $19.95M | $4.45M | 0.44% | -$15.51M |
| Catalyst Pharmaceuticals Inc | 0 | 275,000 | +275,000 | $0 | $4.26M | 0.42% | +$4.26M |
| Roivant Sciences Ltd.SHS(ROIV) | 600,000 | 400,000 | -200,000 | $6.32M | $4.23M | 0.42% | -$2.10M |
| Keros Therapeutics, Inc.(KROS) | 40,000 | 85,000 | +45,000 | $2.65M | $3.88M | 0.39% | +$1.24M |
| Hologic Inc | 0 | 50,000 | +50,000 | $0 | $3.71M | 0.37% | +$3.71M |
| 89bio Inc | 300,000 | 450,000 | +150,000 | $3.49M | $3.60M | 0.36% | +$112.5K |
| Dyne Therapeutics, Inc.(DYN) | 0 | 100,000 | +100,000 | $0 | $3.53M | 0.35% | +$3.53M |
| Scholar Rock Holding Corporation(SRRK) | 325,000 | 400,000 | +75,000 | $5.77M | $3.33M | 0.33% | -$2.44M |
| Cabaletta Bio, Inc.(CABA) | 425,000 | 425,000 | 0 | $7.25M | $3.18M | 0.32% | -$4.07M |
| Editas Medicine, Inc.(EDIT) | 450,000 | 675,000 | +225,000 | $3.34M | $3.15M | 0.31% | -$186.8K |
| Apogee Therapeutics Inc | 40,000 | 80,000 | +40,000 | $2.66M | $3.15M | 0.31% | +$490.0K |
| Nurix Therapeutics, Inc.(NRIX) | 0 | 150,000 | +150,000 | $0 | $3.13M | 0.31% | +$3.13M |
| Fate Therapeutics, Inc.(FATE) | 200,000 | 850,000 | +650,000 | $1.47M | $2.79M | 0.28% | +$1.32M |
| Neurogene Inc.(NGNE) | 0 | 70,000 | +70,000 | $0 | $2.55M | 0.25% | +$2.55M |
| Spyre Therapeutics, Inc.(SYRE) | 100,000 | 100,000 | 0 | $3.79M | $2.35M | 0.23% | -$1.44M |
| Kura Oncology, Inc.(KURA) | 0 | 100,000 | +100,000 | $0 | $2.06M | 0.20% | +$2.06M |
| Revance Therapeutics Inc | 0 | 500,000 | +500,000 | $0 | $1.28M | 0.13% | +$1.28M |
| 4d Molecular Therapeutics In | 250,000 | 0 | -250,000 | $7.96M | $0 | — | -$7.96M |
| AbbVie Inc.(ABBV) | 135,000 | 0 | -135,000 | $24.58M | $0 | — | -$24.58M |
| Agilent Technologies, Inc.(A) | 30,000 | 0 | -30,000 | $4.37M | $0 | — | -$4.37M |
| Align Technology Inc | 15,000 | 0 | -15,000 | $4.92M | $0 | — | -$4.92M |
| Alkermes plcSHS(ALKS) | 250,000 | 0 | -250,000 | $6.77M | $0 | — | -$6.77M |
| Alnylam Pharmaceuticals, Inc.(ALNY) | 50,000 | 0 | -50,000 | $7.47M | $0 | — | -$7.47M |
| Alpine Immune Sciences Inc | 230,000 | 0 | -230,000 | $9.12M | $0 | — | -$9.12M |
| Apellis Pharmaceuticals Inc COM | 150,000 | 0 | -150,000 | $8.82M | $0 | — | -$8.82M |
| Autolus Therapeutics plcADS(AUTL) | 500,000 | 0 | -500,000 | $3.19M | $0 | — | -$3.19M |
| Avantor, Inc.(AVTR) | 500,000 | 0 | -500,000 | $12.79M | $0 | — | -$12.79M |
| Axsome Therapeutics, Inc.(AXSM) | 30,000 | 0 | -30,000 | $2.39M | $0 | — | -$2.39M |
| BeOne Medicines AGADR(ONC) | 40,000 | 0 | -40,000 | $6.26M | $0 | — | -$6.26M |
| Cencora Inc | 50,000 | 0 | -50,000 | $12.15M | $0 | — | -$12.15M |
| Charles River Laboratories International, Inc.(CRL) | 65,000 | 0 | -65,000 | $17.61M | $0 | — | -$17.61M |
| The Cooper Companies, Inc.(COO) | 110,000 | 0 | -110,000 | $11.16M | $0 | — | -$11.16M |
| DexCom, Inc.(DXCM) | 100,000 | 0 | -100,000 | $13.87M | $0 | — | -$13.87M |
| Evolent Health, Inc.CL A(EVH) | 250,000 | 0 | -250,000 | $8.20M | $0 | — | -$8.20M |
| Guardant Health, Inc.(GH) | 150,000 | 0 | -150,000 | $3.09M | $0 | — | -$3.09M |
| Inspire Medical Systems, Inc.(INSP) | 33,000 | 0 | -33,000 | $7.09M | $0 | — | -$7.09M |
| Laboratory Corp Amer Hldgs | 20,000 | 0 | -20,000 | $4.37M | $0 | — | -$4.37M |
| MacroGenics, Inc.(MGNX) | 500,000 | 0 | -500,000 | $7.36M | $0 | — | -$7.36M |
| Natera, Inc.(NTRA) | 50,000 | 0 | -50,000 | $4.57M | $0 | — | -$4.57M |
| Penumbra, Inc.(PEN) | 70,000 | 0 | -70,000 | $15.62M | $0 | — | -$15.62M |
| Regeneron Pharmaceuticals, Inc.(REGN) | 17,000 | 0 | -17,000 | $16.36M | $0 | — | -$16.36M |
| Revvity, Inc.(RVTY) | 50,000 | 0 | -50,000 | $5.25M | $0 | — | -$5.25M |
| Sage Therapeutics Inc | 200,000 | 0 | -200,000 | $3.75M | $0 | — | -$3.75M |
| Shockwave Med Inc | 40,000 | 0 | -40,000 | $13.03M | $0 | — | -$13.03M |
| Tandem Diabetes Care, Inc.(TNDM) | 225,000 | 0 | -225,000 | $7.97M | $0 | — | -$7.97M |
| Walgreens Boots Alliance Inc | 1,300,000 | 0 | -1,300,000 | $28.20M | $0 | — | -$28.20M |